Results 51 to 60 of about 796 (164)

SERS of the new antiepileptic drug cenobamate using gold nanoparticles

LAUREA MAGISTRALEIl monitoraggio terapeutico dei farmaci (TDM) è una pratica clinica comunemente adottata per monitorare la concentrazione di farmaci nel plasma durante un trattamento farmacologico, essenziale per farmaci con indice terapeutico ...
Cutri, Alessia
core  

Cenobamate [PDF]

, 2022
openaire   +1 more source

Cenobamate for the Treatment of Focal Seizures [PDF]

US Neurology, 2020
William E Rosenfeld, Louis Ferrari, Pavel Klein   +2 more
openaire   +1 more source

Efficacy of cenobamate for uncontrolled focal seizures in patients with previous epilepsy-related surgery: Post hoc analysis of a phase 3, multicenter, open-label study

, 2022
Objective: This post hoc analysis of 10 US study sites from a long-term open-label phase 3 study of adjunctive cenobamate evaluated the efficacy of cenobamate in patients with prior epilepsy-related surgery.
Aboumatar, Sami, Sperling, Michael R, Klein, Pavel, Rosenfeld, William E, Krauss, Gregory L, Abou-Khalil, Bassel   +5 more
core  

Issue Information

Epilepsia Open, Volume 11, Issue 3, Page 683-691, June 2026.
wiley   +1 more source

Cost-effectiveness of cenobamate as a therapeutic alternative for the treatment of focal epilepsy in adults with inadequate seizure control

Introduction: This study assesses the cost-effectiveness of cenobamate relative to brivaracetam, lacosamide, eslicarbazepine acetate, and perampanel in the management of focal onset seizures (FOS).
Martina Paoletti, Andrea Marcellusi, Angela Ragonese, Luca Budassi   +3 more
core   +1 more source

Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy

Epilepsia
AbstractObjectivesDevelopmental and epileptic encephalopathies (DEEs) caused by pathogenic variants in SCN8A are associated with difficult‐to‐treat and early‐onset seizures, developmental delay/intellectual disability, impaired quality of life, and increased risk of early mortality.
Cathrine E. Gjerulfsen, Madeleine J. Oudin, Francesca Furia, Sopio Gverdtsiteli, Cecilie Johannessen Landmark, Marina Trivisano, Simona Balestrini, Renzo Guerrini, Angel Aledo‐Serrano, Ricardo Morcos, Roberto Previtali, Pierangelo Veggiotti, Emilia Ricci, Guido Rubboli, Elena Gardella, Rikke S. Møller   +15 more
openaire   +2 more sources

Cenobamate

American Journal of Health-System Pharmacy, 2020
openaire   +1 more source

Oral Presentation

European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Effects of one-year anti-seizure treatment with add-on cenobamate on bone density and bone turnover in adults with drug-resistant focal epilepsy: an observational study

Background and ObjectiveCenobamate is a novel anti-seizure medication (ASM) with unusually high responder rates even in patients with refractory epilepsy.
Hirsch, Martin, Schütz, Elisa, Novitskaya, Yulia A., Schulze-Bonhage, Andreas   +3 more
core   +2 more sources